Nairobi — Access to a twice-yearly HIV prevention injection is moving closer to millions of people in low- and middle-income countries after Dr. Reddy’s Laboratories secured tentative approval from the United States Food and Drug Administration (FDA) for the first generic version of lenacapavir. The regulatory milestone, secured just 16 months after approval of Gilead…
As South Africa becomes the ninth African country to introduce the use of new long-acting drug lenacapavir for HIV prevention, RFI spoke with infectious disease specialist Ndong Essomba Bitchoka about how the treatment works, whether the supply will meet demand and why developing an HIV vaccine remains a challenge. New long-acting antiretroviral treatment lenacapavir requires…
Addis Ababa — Ethiopia has set an excellent example for the rest of the African continent through the Grand Ethiopian Renaissance Dam (GERD), a new benchmark for regional integration, an internationally respected American analyst, Lawrence Freeman, said. The dam, with a 5,150 megawatt of hydroelectric power to the East African nation, was inaugurated on Tuesday…
